| Lily Pearl Speech Therapy, Llc | |
|
824 W 4th St, Bloomington, IN 47404-5012 | |
| (812) 322-0052 | |
| Not Available |
| Full Name | Lily Pearl Speech Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 824 W 4th St, Bloomington, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447691910 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22005087A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lily Pearl Speech Therapy, Llc 824 W. 4th St., Bloomington, IN 47404 Ph: (812) 322-0052 | Lily Pearl Speech Therapy, Llc 824 W 4th St, Bloomington, IN 47404-5012 Ph: (812) 322-0052 |
News Archive
In a new study Dr. Adrian Raine and Yaling Yang of the University of Southern California, and colleagues found that individuals who habitually lied and cheated had less gray matter and more white matter in their prefrontal cortex than normal people.
5N Plus Inc. announced today the closing of a new $250 million senior secured multi-currency revolving credit facility to replace its existing $50 million two-year senior secured revolving facility with National Bank of Canada.
When prescribing newly approved drugs, physicians rely on data from clinical trials to understand the benefits and risks of those drugs for patients. But a study published in the Journal of Oncology Practice showed that for certain cancer drugs, participants in clinical trials are often not representative of the patients that ultimately take the drugs, raising questions about the direct applicability of trial data.
Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step back to move forward.
Only seven per cent of drug applications for treating people with rare diseases were approved in Europe between 2000 and 2004, despite the fact that there are currently more than 5,000 conditions needing medication.
› Verified 9 days ago
Daniel Fogerty, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 | |
Ms. Bettina R Manuel, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3021 E Tapps Turn, Bloomington, IN 47401 Phone: 812-322-7771 Fax: 812-855-5561 | |
Ms. Melanie Jill Mazur, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 S Jordan Ave, Bloomington, IN 47405 Phone: 812-855-3605 | |
Lillian Martindale, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 443 S Landmark Ave, Bloomington, IN 47403 Phone: 812-676-7000 | |
Bell Trace Health And Living Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 Fax: 812-323-2854 | |
Doreen Dotlich Devitt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 S Curry Pike, Bloomington, IN 47403 Phone: 812-330-6700 | |
Chelsea Silverman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2455 N Tamarack Trl, Bloomington, IN 47408 Phone: 812-336-7060 |